ARTA
XBIT icon

A.R.T. Advisors’s XBiotech XBIT Stock Holding History

A.R.T. Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,348
Closed -$101K – 1766
2019
Q2 		$101K Buy
+13,348
New +$116K 0.01% 1191
2018
Q2 		– Sell
-13,915
Closed -$74K – 1793
2018
Q1 		$74K Sell
13,915
-11,378
-45% -$52.4K ﹤0.01% 1375
2017
Q4 		$99K Sell
25,293
-15,533
-38% -$65.4K ﹤0.01% 1257
2017
Q3 		$178K Sell
40,826
-9,480
-19% -$44.8K 0.01% 1152
2017
Q2 		$236K Buy
+50,306
New +$482K 0.01% 1100
2017
Q1 		– Sell
-10,206
Closed -$103K – 1753
2016
Q4 		$103K Buy
+10,206
New +$136K 0.01% 1144

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

A.R.T. Advisors's XBIT Position: Q3 2019 in Review

A.R.T. Advisors sold out of XBiotech (XBIT) in Q3 2019, closing a stake of 13,348 shares — an estimated $101K sold.

A.R.T. Advisors first reported a position in XBIT in Q4 2016 and held it in 6 quarters. The position peaked at $236K in Q2 2017. 47 funds tracked by Wall St. Rank hold XBIT as of Q3 2019.

  • A.R.T. Advisors reported no remaining XBiotech position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 13,348 XBiotech shares in Q3 2019, an estimated $101K.
  • A.R.T. Advisors first reported a position in XBiotech in Q4 2016 and held it in 6 quarters.
  • A.R.T. Advisors's XBiotech position peaked at $236K in Q2 2017.
  • 47 funds tracked by Wall St. Rank held XBiotech as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.